Ups and downs in the search for a Herpes simplex virus vaccine
Modified herpes simplex viruses that are unable to produce glycoprotein D may make effective vaccines.
Main Authors: | Silvia Bolland, Susan K Pierce |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2015-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/06883 |
Similar Items
-
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease
by: Christopher Petro, et al.
Published: (2015-03-01) -
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
by: Christiane Silke Heilingloh, et al.
Published: (2020-08-01) -
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
by: Clare Burn Aschner, et al.
Published: (2020-06-01) -
Advances in Alpha Herpes Viruses Vaccines for Human
by: Madalina Preda, et al.
Published: (2023-06-01) -
Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2
by: Chenhong eLuo, et al.
Published: (2012-04-01)